Tracey Walker

A new survey from Sage Growth Partners offers new ideas on executives’ application and adoption of telemedicine technology.

John R. Washlick, Buchanan, Ingersoll & Rooney, and expert in healthcare system transactions and market consolidation, talks to Managed Healthcare Executive about healthcare spin-offs, what that means for the future of mergers and acquisitions, and advice for healthcare executives.

Survey reveals why 2018 will be the year for telemedicine

A new report reveals the top cities that rise to the top for healthcare-and they’re probably not the cities you’d expect.

A Pacific Research Institute report revealed that the 340B program is in desperate need of reform, while 340B Health refutes damaging claims.

Understanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.

Shift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.

Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.

A KPMG-Leavitt Partners report shows Medicare Advantage and Managed Medicaid are on slightly different trajectories. Expert Ash Shehata shares his predictions for both markets.

The impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.

From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.

How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.

CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know

Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.

With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.

Trump’s new proposal would broaden access to association health plans. Here’s six things to know.

One expert says the interoperability of medical devices, especially of IoT medical devices, creates soft spots in an organization’s security framework.

A sneak peek at the findings from our 2018 Technology Survey reveal where healthcare organizations are struggling most when it comes to interoperability and Big Data.

The regulatory landscape for interoperability is changing, according to Mildred Segura, partner at international law firm Reed Smith.

As multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.

CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.

If 15% to 30% of HCV-infected beneficiaries receive treatment in 2015 with the cost of treatment averaging $84,000, Medicare Part D could increase between $2.9 billion and $5.8 billion